Sachin Naik

发表

In vitro mechanistic study of cell death and in vivo performance evaluation of RGD grafted PEGylated docetaxel liposomes in breast cancer.

A. Misra, A. Mishra, K. Chuttani, 2012, Nanomedicine : nanotechnology, biology, and medicine.

Assessment of In-Vitro Antiproliferative Activity After Intracellular Drug Delivery from Wheat Germ Agglutinin-Conjugated Budesonide Nanoparticles

A. Misra, N. Surti, T. Bagchi, 2007 .

Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases.

A. Misra, Sachin Naik, M. K. Bhalaria, 2009, Indian journal of experimental biology.

Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief

A. Misra, A. Mishra, K. Chuttani, 2013, Journal of drug targeting.

Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain.

A. Misra, Deepa H. Patel, Sachin Naik, 2012, Journal of pharmaceutical sciences.

Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology

A. Misra, N. Surti, Deepa H. Patel, 2010 .

Pharmacokinetic evaluation of wheat germ agglutinin-grafted nanoparticles of mometasone furoate.

A. Misra, N. Surti, Sachin Naik, 2009 .

How and why do endophytes produce plant secondary metabolites?

G. Ravikanth, S. Dayanandan, Sachin Naik, 2019, Symbiosis.

Microemulsion based intranasal delivery system for treatment of insomnia

A. Misra, Tapan Shah, Viral V. Jogani, 2009, Drug delivery.

Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.

A. Ray, H. Ghandehari, H. Bauer, 2011, Molecular pharmaceutics.

Introduction—Biointeractions of Nanomaterials: Challenges and Solutions

Y. Pathak, V. Sutariya, A. Groshev, 2014 .

Intracellular Delivery of Nanoparticles of an Antiasthmatic Drug

A. Misra, N. Surti, T. Bagchi, 2008, AAPS PharmSciTech.

Therapeutic equivalence of vildagliptin 100 mg once daily modified release to 50 mg twice daily immediate release formulation: An open-label, randomized, two-period, single- and multiple-dose, 6-day crossover study.

J Zhang, H. Mittal, S. Kalluri, 2022, Diabetes & metabolic syndrome.

Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases.

A. Misra, Sachin Naik, M. K. Bhalaria, 2009 .

Anti‐neutrophil cytoplasmic antibody‐associated vasculitis with haemolytic uraemic syndrome

Shubham Shukla, R. Ramachandran, M. Rathi, 2022, Internal medicine journal.